RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS
Authors:
- Daniel AbramowiczDADaniel Abramowicz
- Liliane SchandeneLSLiliane Schandene
- Michel GoldmanMGMichel Goldman
- Alain CrusiauxACAlain Crusiaux
- Pierre VereerstraetenPVPierre Vereerstraeten
- Luc DE PauwLPLuc DE Pauw
- Joseph WybranJWJoseph Wybran
- Paul KinnaertPKPaul Kinnaert
- Etienne DupontEDEtienne Dupont
- Charles ToussaintCTCharles Toussaint
- 1 April 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 47 (4) , 606-608
Abstract
High levels of tumor necrosis factor-alpha, interleukin-2, and gamma-interferon appeared in the circulation of kidney transplant recipients after the first injection of the monoclonal antibody OKT3. This initial injection was systematically followed by fever. The three cytokines were released in all patients (n = 9), with peak serum levels of tumor necrosis factor occurring 1 hr after OKT3 injection and those of interleukin-2 and gamma-interferon after 2 hr. Cytokines were not released after the second and third OKT3 injections, when CD3+ cells had disappeared from blood. These findings suggest that circulating cytokines are released by T cells after activation by OKT3. These cytokines are probably involved in the systematic reactions observed after injection of OKT3.Keywords
This publication has 11 references indexed in Scilit:
- Simultaneous production of tumor necrosis factor- alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3.The Journal of Immunology, 1988
- ONE-MONTH PROPHYLACTIC USE OF OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1988
- Identification of a monoclonal antibody specific for a murine T3 polypeptide.Proceedings of the National Academy of Sciences, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Human T cells from autoimmune and normal individuals can produce tumor necrosis factorEuropean Journal of Immunology, 1987
- RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONSThe Lancet, 1986
- Detection of Tumour Necrosis Factor‐Like Cytotoxicity in Serum from Patients With Septicaemia but Not from Untreated Cancer PatientsScandinavian Journal of Immunology, 1986
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complexCell, 1982
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal AllograftsNew England Journal of Medicine, 1981